LLY – Eli Lilly and Company Common Stock

LLY Feed This feed is responsible for generating the rss feed related to the topic lly

  • Drugmakers Are Vying for a Multibillion-Dollar Market
    by The Motley Fool on April 14, 2021 at 12:05 pm

    Autoimmune diseases, such as rheumatoid arthritis, atopic dermatitis, and psoriatic arthritis, offer a multibillion-dollar opportunity for JAK inhibitors. In this video from Motley Fool Live, recorded on March 22, Fool.com contributors Brian Orelli and Keith Speights discuss the

  • Should AbbVie Be Worried About Rinvoq?
    by The Motley Fool on April 14, 2021 at 11:01 am

    The U.S. Food and Drug Administration (FDA) has now pushed back two reviews for regulatory filings by AbbVie (NYSE: ABBV) for Rinvoq. This autoimmune disease drug is an important component of the company's growth strategy. In this Motley Fool Live video, recorded on April 7, 2021

  • March Mailbag: Invest Like a Girl
    by The Motley Fool on April 13, 2021 at 11:38 pm

    Just starting out? Sharing your passion with your family? Reflecting on life's challenges? Bring it on! This is why we invest. In this episode of Rule Breaker Investing, Motley Fool co-founder David Gardner is joined by Motley Fool analysts Maria Gallagher, Karl Thiel, and Rick M

  • A Short Delay Is Still Bad News for AbbVie
    by The Motley Fool on April 13, 2021 at 12:02 pm

    The FDA extended the review for AbbVie's (NYSE: ABBV) Rinvoq as a treatment for psoriatic arthritis. On the surface, a three-month delay isn't a huge deal for the large drugmaker. But as Fool.com Contributors Brian Orelli and Keith Speights discuss in this video from Motley Fool

  • Eli Lilly Appoints Diogo Rau To Head Information Technology And Digital Capabilities
    by RTTNews on April 13, 2021 at 10:43 am

    (RTTNews) - Eli Lilly and Company (LLY) announced Diogo Rau will join on May 17, 2021 as senior vice-president and chief information and digital officer. Rau most recently served as the top executive of information technology for retail and online stores at Apple, Inc. He succeed

1 thought on “LLY – Eli Lilly and Company Common Stock”

  1. Eli Lilly (NYSE: LLY ) shares closed down 9% to $189.16 with Phase 2 data released from its trial of donanemab in patients with Alzheimer’s disease falling short of investor expectations. The company announced earlier this year that the trial met the primary endpoint but it was released over the weekend that it was only just met with a p value of 0.04, scoring just 3.2 points lower on the integrated Alzheimer’s disease rating scale compared with placebo.

Leave a Reply

Your email address will not be published. Required fields are marked *